Basic Information
ID DDInter239
Drug Type small molecule
Molecular Formula C11H20N2O2
Molecular Weight 212.289
CAS Number 357336-20-0
Description Brivaracetam is a racetam derivative of levetiracetam used in the treatment of partial-onset seizures. Brivaracetam binds SV2A with 20 times higher affinity than levetiracetam [A19184]. It is available under the brand name Briviact made by UCB. Briviact received FDA approval on February 19, 2016 [L760].
ATC Classification N03AX23
IUPAC Name (2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl]butanamide
InChI MSYKRHVOOPPJKU-BDAKNGLRSA-N
Canonical SMILES CCC[C@H]1CN([C@@H](CC)C(N)=O)C(=O)C1
Useful Links DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Wikipedia ChEMBL ZINC
Interactions with Brivaracetam
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note